To test our hypothesis that the enhanced transcription of IFNγ-related genes in HD condition in ER+ breast cancer cells is through NF-κB signaling, we first assessed the levels of RelA (p65), the subunit of the canonical NF-κB complex that contains the transcriptional transactivation domain (TAD). The gene discussed is IFNG; the disease is breast carcinoma.